LUNG NEOPLASMS

This program provides access to the experimental drug taletrectinib for adults with advanced ROS1-positive lung cancer who have run out of approved treatment options and cannot join regular clinical trials. The drug aims to control cancer growth in patients who have already tried…

This study looked back at existing medical records to see if using special 4DCT scans to create a map of a patient's best-working lung tissue could help guide radiation therapy. Doctors compared standard radiation plans to new plans designed to avoid these healthy lung areas, aim…

This study is testing whether new technology can make radiation therapy for lung cancer more precise. It aims to adjust the radiation beam in real-time to follow a tumor's movement as a patient breathes. The research involves 20 patients to see if this tracking method is practica…

This study is testing whether a shorter, more intense course of proton radiation therapy, given alongside standard chemotherapy, is safe and effective for people with stage II or III non-small cell lung cancer. Proton therapy is a precise type of radiation that aims to better tar…

This early-stage study is testing a new personalized cell therapy called KSQ-001EX in people with advanced melanoma, lung cancer, or head and neck cancer. Doctors take a patient's own immune cells from a tumor, genetically modify them to potentially be more powerful, and then inf…

This study is observing how well a combination of the drug Osimertinib and standard chemotherapy works for people with a specific type of advanced lung cancer (EGFR-positive NSCLC) in a real-world setting. It involves 532 adult patients who have already started this specific trea…

This study aims to see if providing standardized training to cancer doctors in smaller city and county hospitals leads to better testing and treatment for patients with advanced non-small cell lung cancer. It will follow 1,000 patients to measure if doctors order more recommended…